ReviewAllergy, asthma & immunology research2026
Work-Related Asthma: An Occupational Medicine Perspective.
Review in Allergy, asthma & immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Work-related asthma (WRA), encompassing occupational asthma and work-exacerbated asthma, is among the most prevalent yet preventable occupational respiratory diseases, with population-based studies estimating that 10% to 25% of adult asthma cases are attributable to workplace exposure. This review examines epidemiology, causative agents, pathogenesis, clinical evaluation, management, and WRA prevention from an occupational medicine perspective, with emphasis on Korean surveillance data. The Korea Work-related Asthma Surveillance program (2004-2009) identified 236 cases with a crude incidence of 3.31 per million workers, revealing a 40- to 90-fold detection gap when compared to European population-based estimates of 250 to 300 per million workers annually. Korean cases showed a distinctive agent profile, with isocyanates accounting for 46.6%-a figure that far exceeds the 13% to 23% in Western surveillance systems-which reflects the prominence of the furniture manufacturing industry. Temporal trends demonstrated successful prevention, with isocyanate-related cases decreasing from 65.0% to 26.9% during the period 2004-2009. Despite treatment advances, the prognosis remains poor: only 32% of patients achieve symptomatic recovery following the complete avoidance of exposure, and continued exposure increases the symptom burden 10-fold. Workers' compensation data confirm persistent underdiagnosis, with only 0 to 5 cases annually approved during the period 2013-2023 despite expanding recognition of occupational diseases overall. The Korea Occupational Disease Surveillance Center, established in 2022, offers an opportunity to bridge the prolonged surveillance gap. Clinicians treating working adults should maintain a high index of suspicion for the occupational causes of asthma, pursue early diagnosis and exposure cessation, and integrate workplace assessments into their routine clinical evaluations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.